Romosozumab prevents clinical fracture slightly better than alendronate in women with osteoporosis and previous fracture

Romosozumab prevents clinical fracture slightly better than alendronate in women with osteoporosis and previous fracture is a topic covered in the EE+ POEM Archive.

To view the entire topic, please sign in or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

20 mcg versus >20 mcg estrogen combined oral contraceptives for contraception

"Snowball fingers" - Image

Botulinum toxin for the treatment of strabismus: Cochrane systematic review

ACC/AHA: Fewer patients require prophylaxis for endocarditis

Citation

Barry, Henry, et al., editors. "Romosozumab Prevents Clinical Fracture Slightly Better Than Alendronate in Women With Osteoporosis and Previous Fracture." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314414/all/Romosozumab_prevents_clinical_fracture_slightly_better_than_alendronate_in_women_with_osteoporosis_and_previous_fracture.

Romosozumab prevents clinical fracture slightly better than alendronate in women with osteoporosis and previous fracture. In: Barry H, Ebell MH, Shaughnessy AF, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314414/all/Romosozumab_prevents_clinical_fracture_slightly_better_than_alendronate_in_women_with_osteoporosis_and_previous_fracture. Accessed January 17, 2019.

Romosozumab prevents clinical fracture slightly better than alendronate in women with osteoporosis and previous fracture. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. Available from https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314414/all/Romosozumab_prevents_clinical_fracture_slightly_better_than_alendronate_in_women_with_osteoporosis_and_previous_fracture

Romosozumab Prevents Clinical Fracture Slightly Better Than Alendronate in Women With Osteoporosis and Previous Fracture [Internet]. In: Barry H, Ebell MH, Shaughnessy AF, Slawson DC, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2019 January 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314414/all/Romosozumab_prevents_clinical_fracture_slightly_better_than_alendronate_in_women_with_osteoporosis_and_previous_fracture

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case

TY - ELEC T1 - Romosozumab prevents clinical fracture slightly better than alendronate in women with osteoporosis and previous fracture ID - 1314414 ED - Barry,Henry, ED - Ebell,Mark H, ED - Shaughnessy,Allen F, ED - Slawson,David C, BT - EE+ POEM Archive UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314414/all/Romosozumab_prevents_clinical_fracture_slightly_better_than_alendronate_in_women_with_osteoporosis_and_previous_fracture PB - John Wiley & Sons DB - Evidence Central DP - Unbound Medicine ER -